Story Poster
Oklahoma State Football

Alan Bowman Pokes Report NIL Journal No. 17 - Rough Game is a Win, Now Play for it All

November 29, 2023
2,854

Publisher’s Note: This is the 17th installment of the Pokes Report NIL Journal for the 2023 football season. Alan Bowman takes full accountability for several rough plays that led to the halftime deficit in the final regular season game with BYU.

To watch this video, you must be a Pokes Report Premium subscriber.
Discussion from...

Alan Bowman Pokes Report NIL Journal No. 17 - Rough Game is a Win, Now Play for it All

2,479 Views | 6 Replies | Last: 11 mo ago by Imapoke
RodeoPoke
How long do you want to ignore this user?
Can't wait to see you there and Go Pokes!


Classic
TUSKAPOKE
How long do you want to ignore this user?
Thanks for another report. Go get some Shorthorn steaks Saturday. GO POKES!!!
Orangeheart72
How long do you want to ignore this user?
For whatever reason, OSU has had UT's number for a dozen years. That's a nice trend but we're likely UT's favorite team to beat behind OU due to that fact. I just hope our team plays their A game. OU beat them, Houston could have beat them, TCU played a 3 point loss against them yet lost to KState by almost 40 points. Nothings settled or impossible. Less talented teams have made bigger upsets (see S. Alabama). Pokes could make a wonderful statement for Big XII here! Go Cowboys!!
TXPokeEnding
How long do you want to ignore this user?
We need to come out on absolute fire, like we did against Miami in 2020. Break tendencies. Surprise 'em. Punch 'em in the mouth.

Go Pokes!
Eddy Hackleman
How long do you want to ignore this user?
Thanks for the update... Beat Texas! Go Pokes!!
Imapoke
How long do you want to ignore this user?
Read yesterday that if you take out Bowman's games in the rain that he and Ewers stats are the same. No rain in Jerry World!.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.